USRE30560EExpiredUtility
Oxazolidinedione derivatives of Vinca alkaloids
Priority: Dec 6, 1976Filed: Nov 2, 1979Granted: Mar 31, 1981
Est. expiryDec 6, 1996(expired)· nominal 20-yr term from priority
C07D 519/04
35
PatentIndex Score
4
Cited by
4
References
7
Claims
Abstract
3-Spiro-5"-oxazolidine-2",4"-dione derivatives of Vinca alkaloids, useful as anti-tumor agents and as intermediates.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A compound of the formula ##STR5## wherein R is H, C 1 -C 4 alkyl; C 3 -C 4 alkenyl, CH 2 --CHX--CH 3 or CH 2 --CH 2 X; wherein X is Br or Cl; R 1 is OH, ##STR6## R 2 is H, CH 3 or CHO; one of R 3 and R 4 , when taken singly, is H or OH and the other C 2 H 5 ; R 5 , when taken singly, is H; and R 4 and R 5 , when taken together, form an epoxide; and pharmaceutically-acceptable salts thereof.
2. A compound according to claim 1, said compound being VLB 3"-methyl-3-spiro-5"-oxazolidine-2",4"-dione.
3. The sulfate salt of the compound of claim 2.
4. A compound according to claim 1 said compound being VLB 3"-(β-chloroethyl)-3-spiro-5"-oxazolidine-2",4"-dione.
5. The sulfate salt of the compound of claim 4.
6. A compound according to claim 1 wherein R 1 is OH.
7. A compound according to claim 1 wherein R 1 is ##STR7##Join the waitlist — get patent alerts
Track USRE30560E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.